Quadruple injection of hypothalamic peptides to evaluate pituitary function in normal subjects

Area of Science:

• Endocrinology
• Neuroendocrinology
• Pituitary Physiology

Background:

• Hypothalamic releasing hormones regulate anterior pituitary function.
• Assessing anterior pituitary reserve is crucial for diagnosing endocrine disorders.
• Previous methods like insulin-induced hypoglycemia have limitations.

Purpose of the Study:

• To evaluate the efficacy of a quadruple bolus of hypothalamic releasing hormones in stimulating anterior pituitary hormone release in normal subjects.
• To compare the response to the quadruple bolus with established tests like insulin-induced hypoglycemia and the metyrapone test.
• To determine the optimal combination of releasing hormones for pituitary function testing.

Main Methods:

• Administration of a single intravenous injection of four hypothalamic releasing hormones (corticotropin-, growth hormone-, gonadotropin-, and thyrotropin-releasing hormones) to normal subjects.
• Measurement of plasma levels of anterior pituitary hormones (ACTH, GH, prolactin, TSH, LH, FSH).
• Comparison of results with insulin-induced hypoglycemia and a single-dose overnight metyrapone test in the same individuals.

Main Results:

• A statistically significant increase in all anterior pituitary hormone levels, except plasma ACTH, was observed after the quadruple bolus.
• Transient flushing was the only consistent side effect.
• The quadruple bolus showed a greater prolactin increment than insulin-induced hypoglycemia but a lesser ACTH increment than the metyrapone test.

Conclusions:

• A quadruple bolus of hypothalamic peptides is not optimal for studying pituitary function.
• A combination of a metyrapone test with a triple bolus (GH-, TSH-, GnRH-releasing hormones) is effective for assessing pituitary function in normal subjects.
• This combined approach provides more information with fewer side effects compared to insulin-induced hypoglycemia.